{"transactions":[{"id":752503,"issuer":{"id":6721,"kind":"organization","name":"ONCOLYTICS BIOTECH INC"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-03T20:30:26.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.06,"expiration_date":"2036-06-01","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-26-027083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129928/000149315226027083/ownership.xml","form_type":"4"}},{"id":827711,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-26T21:33:13.000Z","date":"2026-03-25","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in three equal annual installments starting on March 25, 2027, subject to the Reporting Person's continuous service (as defined in the Issuer's 2018 Equity Incentive Plan) with the Issuer through each such vesting date."}],"balance_after":270000,"derivative":{"exercise_price":1.57,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001445710-26-000004","document":"form4-03262026_090309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000144571026000004/form4-03262026_090309.xml","form_type":"4"}},{"id":905630,"issuer":{"id":6721,"kind":"organization","name":"ONCOLYTICS BIOTECH INC"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-02-13T12:00:21.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":35400,"price":0.8557,"value":30291.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8483 to $0.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":78128,"source":{"system":"sec-edgar","filing":"0001493152-26-006540","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129928/000149315226006540/ownership.xml","form_type":"4"}},{"id":1531906,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-01T16:26:00.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 1, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.62,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-011862","document":"form4-05012024_080551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000141588924011862/form4-05012024_080551.xml","form_type":"4"}},{"id":1696416,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-01-02T16:05:26.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":5191,"price":2.36,"value":12250.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $12,250."}],"balance_after":58608,"source":{"system":"sec-edgar","filing":"0001209191-24-000069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919124000069/doc4.xml","form_type":"4"}},{"id":1767298,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-10-03T16:05:33.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":8167,"price":1.5,"value":12250.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $12,250."}],"balance_after":53417,"source":{"system":"sec-edgar","filing":"0001209191-23-051392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919123051392/doc4.xml","form_type":"4"}},{"id":1882502,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-22T16:20:15.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.98,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-031446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919123031446/doc4.xml","form_type":"4"}},{"id":2261752,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T16:06:09.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 18, 2023, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":0.6,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-22-030966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919122030966/doc4.xml","form_type":"4"}},{"id":2504679,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T16:05:36.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":40000,"price":2.05,"value":82000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $2.03 to $2.07 per share, with a weighted average purchase price of $2.05 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":45250,"source":{"system":"sec-edgar","filing":"0001209191-21-065434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919121065434/doc4.xml","form_type":"4"}},{"id":2693152,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-27T20:54:00.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":10500,"derivative":{"exercise_price":2.55,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-21-036380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919121036380/doc4.xml","form_type":"4"}},{"id":2693151,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T20:54:00.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying these restricted stock units vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001209191-21-036380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919121036380/doc4.xml","form_type":"4"}},{"id":3133638,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-27T16:27:11.000Z","date":"2020-05-22","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 22, 2021, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":3,"expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-20-032299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919120032299/doc4.xml","form_type":"4"}},{"id":3516810,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-21T16:11:26.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":12.39,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-19-031734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919119031734/doc4.xml","form_type":"4"}},{"id":3923958,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-21T16:14:53.000Z","date":"2018-05-18","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":18.41,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-18-031812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919118031812/doc4.xml","form_type":"4"}},{"id":4285463,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":41894,"kind":"person","name":"Andrews Patricia S","position":1,"cik":"0001445710","reported_name":"Andrews Patricia S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-12T16:26:34.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant was made pursuant to the issuer's non-employee director compensation policy. The shares underlying this option vest in three equal installments on June 9, 2018, 2019 and 2020, subject to the reporting person's continuous service with the issuer at each vesting date."}],"balance_after":22000,"derivative":{"exercise_price":11.63,"expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-17-039165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445710/000120919117039165/doc4.xml","form_type":"4"}}]}